Eli Lilly and Co (WAR:LILY) Cyclically Adjusted Book per Share: zł55.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:LILY Eli Lilly and Co WAR:LILY
96 GF Score
Price zł4,640.00
GF Value zł6,179.44
! 3 Warning Signs
View Full Analysis

What is Eli Lilly and Co Cyclically Adjusted Book per Share?

Eli Lilly and Co WAR:LILY 96 Cyclically Adjusted Book per Share is zł55.05 as of Jun. 2026. GuruFocus rates WAR:LILY with a GF Score™ of 96/100 and a GF Value™ of zł6,179.44. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted book value per share for the three months ended in Jun. 2026 was zł141.162. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł55.05 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted Book Growth Rate was 14.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eli Lilly and Co was 8.80% per year. The lowest was -2.00% per year. And the median was 3.70% per year.

As of today (2026-09-06), Eli Lilly and Co's current stock price is zł4640.00. Eli Lilly and Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was zł55.05. Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is 84.29.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 87.86. The lowest was 5.24. And the median was 19.14.


Eli Lilly and Co  (WAR:LILY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4640.00/55.05
=84.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 87.86. The lowest was 5.24. And the median was 19.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eli Lilly and Co Cyclically Adjusted Book per Share Related Terms


Eli Lilly and Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Cyclically Adjusted Book per Share Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eli Lilly and Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 54.12 55.05

WAR:LILY vs JNJ, ABBV, MRK: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted PB Ratio falls into.


WAR:LILY
96GF Score
Eli Lilly and Co WAR:LILY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=141.162/333.9520*333.9520
=141.162

Current CPI (Jun. 2026) = 333.9520.

Eli Lilly and Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 52.454 241.428 72.556
201612 47.265 241.432 65.378
201703 47.235 243.801 64.701
201706 47.574 244.955 64.859
201709 50.233 246.819 67.966
201712 39.145 246.524 53.027
201803 49.384 249.554 66.085
201806 39.966 251.989 52.966
201809 45.508 252.439 60.203
201812 34.539 251.233 45.911
201903 9.490 254.202 12.467
201906 10.692 256.143 13.940
201909 13.087 256.759 17.022
201912 10.113 256.974 13.142
202003 11.951 258.115 15.462
202006 15.895 257.797 20.590
202009 18.745 260.280 24.051
202012 21.907 260.474 28.087
202103 26.708 264.877 33.673
202106 25.025 271.696 30.759
202109 30.121 274.310 36.670
202112 34.975 278.802 41.893
202203 36.461 287.504 42.351
202206 33.404 296.311 37.647
202209 39.367 296.808 44.294
202212 41.633 296.797 46.845
202303 43.789 301.836 48.448
202306 43.293 305.109 47.386
202309 43.905 307.789 47.637
202312 44.489 306.746 48.435
202403 52.856 312.332 56.515
202406 55.948 314.175 59.470
202409 58.782 315.301 62.259
202412 59.066 315.605 62.500
202503 65.230 319.799 68.117
202506 75.684 322.561 78.357
202509 98.658 324.800 101.438
202512 110.154 324.054 113.519
202603 129.700 330.213 131.169
202606 141.162 333.952 141.162

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of zł55.05 mean?
Eli Lilly and Co (WAR:LILY) has a Cyclically Adjusted Book per Share of zł55.05 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Cyclically Adjusted Book per Share too high?
Eli Lilly and Co's current Cyclically Adjusted Book per Share is zł55.05. Overall, Eli Lilly and Co has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Cyclically Adjusted Book per Share compare to JNJ and ABBV?
Eli Lilly and Co's Cyclically Adjusted Book per Share of zł55.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current Cyclically Adjusted Book per Share is zł55.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Eli Lilly and Co (WAR:LILY) has a current Cyclically Adjusted Book per Share of zł55.05. The stock's GF Value™ is zł6,179.44, compared to a current price of zł4,640.00 — trading 24.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is zł55.05. Eli Lilly and Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Eli Lilly and Co (WAR:LILY), the current Cyclically Adjusted Book per Share is zł55.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (WAR:LILY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of zł4,640.00 is trading 24.9% below its estimated GF Value™ of zł6,179.44.

Key valuation signals for WAR:LILY:

  • Cyclically Adjusted Book per Share: zł55.05
  • GF Value™: zł6,179.44 vs. price of zł4,640.00 (24.9% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the WAR:LILY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
96GF Score

Get the complete analysis for WAR:LILY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł4,640.00
Price
zł6,179.44
GF Value